Results 161 to 170 of about 7,967 (189)

Inclusion body myositis: an update

Current Opinion in Rheumatology
Purpose of review To review recent advances in our understanding of the epidemiology, pathophysiology, and management of inclusion body myositis (IBM). Recent findings Recent epidemiologic studies have highlighted the morbidity and mortality associated with IBM, including the impact
Nicolaas C, Anderson, Thomas E, Lloyd
openaire   +2 more sources

Biomarkers of inclusion body myositis

Current Opinion in Rheumatology, 2013
Inclusion body myositis (IBM) is a poorly understood autoimmune and degenerative disorder of skeletal muscle. Here, pathophysiological and diagnostic biomarkers of IBM are reviewed.Muscle histopathological biomarkers have been successful in stimulating the study of IBM pathophysiology for over three decades.
openaire   +2 more sources

Treatment of inclusion body myositis

Current Opinion in Rheumatology, 1999
Sporadic inclusion body myositis (s-IBM) is considered the most common muscle disease in patients older than 50 years, with a male predominance. Features of s-IBM include insidious onset, slowly and relentlessly progressive muscle weakness, a characteristic distribution and atrophy of both the proximal and distal muscle groups, and resistance to ...
openaire   +2 more sources

Inclusion Body Myositis—A Review

Advances in Anatomic Pathology, 1998
Inclusion body myositis (IBM), a sporadic inflammatory myopathy, is the most frequently occurring progressive myopathy in adults older than 55 years. It more commonly affects men and usually is clinically and pathologically distinguishable from dermatomyositis or polymyositis.
openaire   +2 more sources

Leukocytapheresis in inclusion body myositis

Journal of Clinical Apheresis, 1987
AbstractA patient with inclusion body myositis was treated with a course of 22 leukocytaphereses combined with prednisone and azathioprine therapy. He improved clinically during an induction phase of frequent cytapheresis, which reduced the circulating levels of T lymphocytes and monocytes and decreased the ratio of the T4+ to T8+ lymphocyte subsets ...
openaire   +2 more sources

Achalasia and Inclusion Body Myositis

American Journal of Gastroenterology, 2023
Amrit K. Kamboj, Pannathat Soontrapa, Divyanshu Dubey, Teerin Liewluck, Cadman L. Leggett   +4 more
openaire   +2 more sources

[Inclusion body myositis].

Ideggyogyaszati szemle, 2015
The idiopathic inflammatory myopathies are systemic, chronic autoimmune diseases characterized by proximal symmetrical muscle weakness. One of the main diseases in this group is inclusion body myositis (IBM), an underdiagnosed, progressive muscle disease characteristically affecting the middle-aged and older population.
Levente, Bodoki, Melinda, Vincze, Zoltán, Griger, Tamás, Csonka, Katalin, Dankó, Tibor, Hortobágyi   +5 more
openaire   +1 more source

['Inclusion body'-myositis].

Nederlands tijdschrift voor geneeskunde, 1998
In 3 patients, a 72-year-old man, a 62-year-old man and a 73-year-old woman with weakness of respectively the quadriceps femoris, the finger flexors and the pharyngeal muscles, the diagnosis of 'inclusion body myositis' was made. This is a rare, slowly progressive skeletal muscle disorder which is more common in men and after the age of fifty.
U A, Badrising, M L, Maat-Schieman, S G, van Duinen, J G, van Dijk, J J, Verschuuren, A R, Wintzen   +5 more
openaire   +1 more source

Atypical presentations of inclusion body myositis: Clinical characteristics and long‐term outcomes

Muscle and Nerve, 2022
Mazen Alamr, Marcus V Pinto, Elie Naddaf   +2 more
exaly  

Long-term observational study of sporadic inclusion body myositis

Brain, 2011
Olivier Benveniste, O Dubourg, W Squier   +2 more
exaly